CYTOMX THERAPEUTICS I

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

21 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

18 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

11 مارس 2024 15:10:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CYTOMX THERAPEUTICS INC. - COMMON STOCK

04 مارس 2024 12:12:49 بحسب NetDania Notify

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

04 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CYTOMX THERAPEUTICS INC. - COMMON STOCK

01 مارس 2024 12:17:46 بحسب NetDania Notify

NetDania - New 12 months High: CYTOMX THERAPEUTICS INC. - COMMON STOCK

28 فبراير 2024 10:19:37 بحسب NetDania Notify

NetDania - New 12 months High: CYTOMX THERAPEUTICS INC. - COMMON STOCK

27 فبراير 2024 11:18:02 بحسب NetDania Notify

CytomX Therapeutics to Present at Upcoming March Investor Conferences

27 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

24 يناير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference

12 يناير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Outlines 2024 Company Priorities and Milestones

04 يناير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

21 ديسمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

07 نوفمبر 2023 15:15:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming November Investor Conferences

01 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023

31 أكتوبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting

30 أكتوبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference

18 أكتوبر 2023 15:30:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming September Investor Conferences

05 سبتمبر 2023 15:05:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference

10 أغسطس 2023 15:05:00 بحسب Nasdaq GlobeNewswire